Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-10 | 2017-11-07 | 167 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-25 | 202 |
| TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Resolved | 2017-03-13 | 2020-01-21 | 952 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 974 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2017-03-13 | 2019-05-28 | 983 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2017-03-13 | 2017-04-03 | 989 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1026 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1035 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1038 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1137 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1153 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1161 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1167 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1175 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1179 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1191 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |